罗格列酮抑制CsA引起的大鼠肝细胞TGF-β1和FIBRONECTIN的表达
被引量:1
出处
《基础医学与临床》
CSCD
北大核心
2009年第2期198-200,共3页
Basic and Clinical Medicine
基金
河南省科技攻关项目(0324410084)
河南省杰出青年基金(74100510006)
参考文献1
-
1Fabio Marra,Raffaella DeFranco,Gaia Robino,Erica Novo,Eva Efsen,Sabrina Pastacaldi,Elena Zamara,Alessandro Vercelli,Benedetta Lottini,Carlo Spirli,Mario Strazzabosco,Massimo Pinzani,Maurizio Parola.Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis[J].World Journal of Gastroenterology,2005,11(32):4931-4938. 被引量:9
二级参考文献47
-
1Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003; 38:S38-S53.
-
2Cassiman D, Roskams T. Beauty is in the eye of the beholder:emerging concepts ad pitfalls in hepatic stellate cell research.J Hepatol 2002; 37:527-535.
-
3Desmet V, Roskams T, Van Eyken P. Ductular reaction in the liver. Pathol Res Pract 1995; 191:513-524.
-
4Morland CM, Fear J, I~cNab G, Joplin R, Adams DH. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro.Proc Assoc Am Physicians 1997; 109:372-382.
-
5Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S,Arrighi MC, Pinzani M, Laffi G, Montalto P, Gentilini P. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999; 29:140-148.
-
6Park J, Gores GJ, Patel T. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase.Hepatology 1999; 29:1037-1043.
-
7Ishida Y, Smith S, Wallace L, Sadamoto T, Okamoto M,Auth M, Strazzabosco M, Fabris L, Medina J, Prieto J, Strain A, Neuberger J, Joplin R. Ductular morphogenesis and functional polarization of normal human biliary epithelial cells in three-dimensional culture. J Hepatol 2001; 35:2-9.
-
8Knittel T, Kobold D, Piscaglia F, Saile B, Neubauer K, Mehde M, Timpl R, Ramadori G. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers:distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol 1999; 112:387-401.
-
9Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T.Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002; 36:200-209.
-
10Kinnman N, Francoz C, Barbu V, Wendum D, Rey C,Hultcrantz R, Poupon R, Housset C. The myofibroblastic conversion of.peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 2003; 83:163-173.
共引文献8
-
1陈科全,周宇.PPAR-γ与肝纤维化关系研究现状[J].实用肝脏病杂志,2006,9(2):111-113.
-
2胡冬梅,杨大明.过氧化物酶体增殖物激活受体γ与肝纤维化关系的研究进展[J].胃肠病学和肝病学杂志,2007,16(4):391-392.
-
3王河焱,周晓倩,程明亮.丹芍化纤胶囊抗肝纤维化治疗对大鼠过氧化物酶体增殖物激活受体-γ表达的影响[J].中华肝脏病杂志,2007,15(11):859-860. 被引量:4
-
4程根阳,李建生,刘章锁,梁献慧,王沛.罗格列酮对环孢素A致大鼠肝脏纤维化的改善作用[J].中国组织工程研究与临床康复,2008,12(31):6063-6068. 被引量:1
-
5林箐,刘新民,唐朝枢.过氧化物酶体增殖物激活受体γ与器官纤维化[J].生理科学进展,2008,39(4):335-338. 被引量:5
-
6郑永超,孙勇伟.过氧化物酶体增殖物激活受体γ在肝纤维化中作用[J].内科理论与实践,2010,5(1):103-106.
-
7黄海燕,刘利则,于燕,杜玉茗.丹参联合罗格列酮对db/db糖尿病小鼠肝纤维化的干预作用[J].中国老年学杂志,2012,32(10):2082-2084. 被引量:3
-
8鲁苏日古嘎,刘霆,朱单单,余思佳,卢礼卿,丁俊杰.肝纤维化相关信号通路及其相应的抗肝纤维化药物研究进展[J].临床肝胆病杂志,2022,38(5):1161-1164. 被引量:9
同被引文献8
-
1Assaly R, de Tassigny Ad, Paradis S, et al. Oxidative stress, mitochondrial permeability transition pore opening and cell death during hypoxia-reoxygenation in adult cardio- myocytes [J]. Eur J Pharmacol, 2012, 675:6- 14.
-
2Schwarzkopf TM, Hagl S, Eckert GP, et al. Neuroprotec- tion by bilobalide in ischemia: improvement of mitochondri- al function [J]. Pharmazie, 2013, 68:584- 589.
-
3Gill RS, Lee TF, Manouchehri N, et al. Postresuscitation cyclosporine treatment attenuates myocardial and cardiac mitochondrial injury in newborn piglets with asphyxla-reox- ygenation [J]. Crit Care Med, 2013, 41:1069- 1074.
-
4Yang GM, Li T, Xu J, et al. PKC plays an important me- diated effect in arginine vasopressin induced restoration of vascular responsiveness and calcium sensitization following hemorrhagic shock in rats [J]. Eur J Pharmacol, 2010, 628 : 148 - 154.
-
5Li T, Lin X, Zhu Y, et al. Short-term, mild hypothermia can increase the beneficial effect of permissive hypotension on uncontrolled hemorrhagic shock in rats [ J ]. Anesthesi- ology, 2012, 116:1288 - 1298.
-
6Wirth A, Beny6 Z, Lukasova M, et al. G12-G13-LARG- mediated signaling in vascular smooth muscle is required for salt-induced hypertension [ J ]. Nat Med, 2008, 14 : 64 - 68.
-
7杨光明,李涛,徐竞,唐婧,刘良明.ERK和P38 MAPK升高MLC_(20)磷酸化调节大鼠平滑肌低氧反应性[J].基础医学与临床,2011,31(4):366-370. 被引量:5
-
8雷艳,董兆君.环孢素A对大鼠缺血缺氧后酸碱平衡的调节作用[J].局解手术学杂志,2013,22(4):374-376. 被引量:4
二级引证文献3
-
1雷艳,杨新征,董昭君.Rho激酶和PKC在环孢素A改善休克血管反应性中的作用及与MPTP的关系[J].局解手术学杂志,2015,24(4):355-358. 被引量:2
-
2沈彦艳,陆关珍.综合性护理干预措施对创伤失血性休克患者救治的效果及护理质量分析[J].中国现代医生,2017,55(8):165-168. 被引量:2
-
3彭小勇,周海军,李涛,刘良明,杨光明.钙敏感性受体抑制剂Calhex231对创伤失血性休克大鼠的保护作用[J].中华创伤杂志,2018,34(6):555-561. 被引量:3
-
1邓卓军,赵彩彦.过氧化物酶体增殖物激活受体α与非酒精性脂肪性肝炎[J].国外医学(消化系疾病分册),2005,25(5):275-278. 被引量:1
-
2姚园,江洪.过氧化物酶体增殖物激活受体γ的心血管保护作用[J].岭南心血管病杂志,2006,12(6):445-448. 被引量:3
-
3汪贵姣,王达莉,杨柳,徐曾文,宋玉莹.胰岛素笔治疗2型糖尿病的护理干预[J].护理实践与研究,2010,7(9):31-32. 被引量:3
-
4刘慧.静脉滴注阿奇霉素致过敏性休克1例[J].人民军医,2014,57(8):895-895.
-
5张子波,吕福庆,王伟杰,李博,杨康鹃,金元哲.过氧化物酶体增殖受体γ辅激活因子-1多态性与2型糖尿病相关性研究[J].现代预防医学,2008,35(20):4048-4050. 被引量:1
-
6石少慧,王怀颖,张晶晶,靳祎,辛海涛.灯盏花素对肾缺血再灌注过氧化物酶体损伤的保护作用[J].军医进修学院学报,2006,27(6):438-439. 被引量:12
-
7黄洁丽,原爱红.过氧化物酶体增殖物激活受体γ与糖尿病肾病[J].第二军医大学学报,2006,27(12):1372-1374. 被引量:1
-
8罗燕军,于皆平,罗和生,刘诗权,涂希平.银杏叶提取物对四氯化碳诱发大鼠肝纤维化的预防作用[J].中华消化杂志,2004,24(5):307-308. 被引量:33
-
9谭力学,李孝生,刘增权,刘梁英.川芎嗪和大黄酸联用对大鼠肝纤维化的抑制作用[J].中华肝脏病杂志,2004,12(11):692-693. 被引量:10
-
10敬锐,林文华.替格瑞洛在急性心肌梗死患者急诊经皮冠状动脉介入治疗中的应用[J].中国医药,2016,11(9):1279-1282. 被引量:26